RankAlpha logo
Back to Rankings

LIXT

Lixte BiotechnologyF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
LIXT vs peer average
32/100
LIXT vs. peer average (F vs. D)
Grade spread
B 2 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

OKYO is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $87.33M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerOKYOOKYO
LIXT
Lixte Biotechnology
OKYO
OKYO
Grade
F
F
Momentum
35
29
Value
42
49
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs OKYO

LIXT / OKYO
Grade Position
Below peers
LIXT vs. peer average (F vs. D)
32/100
Momentum
35
LIXT
Value
42
OKYO
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LIXT
1
OKYO
OKYO Pharma Ltd Common
F
20/100
Even
2
IBIO
iBio Inc Common
B
80/100
-3
3
AARD
Aardvark Therapeutics Inc Common
N/A
-
-
4
CPIX
Cumberland Pharmaceuticals Inc Common
B
80/100
-3
5
FBIO
Fortress Biotech Inc Common
D
40/100
-1
OKYO is the first peer returned for this comparison set.